Discovery of Protective Genetic Variants to Develop Disease Modifying Therapeutics for ALS
Time: 2:30 pm
day: Conference Day One Track A PM
Details:
- Unpacking the role of genetic heterogeneity in ALS
- Shifting perspective – protective genetic variants in nonneuronal genes that impact disease progression and survival
- Development of targeted disease modifying therapeutics
